• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用围手术期护理计划缩短根治性膀胱切除术患者恢复经口饮食和出院的时间。

Reducing time to oral diet and hospital discharge in patients undergoing radical cystectomy using a perioperative care plan.

作者信息

Pruthi Raj S, Chun Judy, Richman Marc

机构信息

Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA.

出版信息

Urology. 2003 Oct;62(4):661-5; discussion 665-6. doi: 10.1016/s0090-4295(03)00651-4.

DOI:10.1016/s0090-4295(03)00651-4
PMID:14550438
Abstract

OBJECTIVES

To outline our current perioperative treatment of patients undergoing radical cystectomy and urinary diversion, which uses advancements in perioperative care to allow for early institution of an oral diet and early hospital discharge, and thereby overall improvement in patient recovery and outcome after this procedure.

METHODS

Forty consecutive patients underwent radical cystectomy and urinary diversion with curative intent from 2001 to 2002. A care plan was followed for all patients and included improvements in preoperative, intraoperative, and postoperative care. The preoperative care included limited outpatient bowel preparation with sodium phosphate solution and patient education. Operative modifications included reduced incision length, initial preperitoneal dissection, and the use of internal surgical stapling devices. The postoperative care included the use of prokinetic agents, early nasogastric tube removal, the use of non-narcotic analgesics, and early institution of an oral diet. The outcomes with regard to time to institution of an oral diet, tolerance of a regular diet, and hospital discharge were assessed.

RESULTS

The mean surgical time was 3.9 hours, and the mean estimated blood loss was 573 mL. The mean time to the institution of a clear liquid diet was 2.0 days and to a regular diet was 4.2 days. The mean time to hospital discharge was 5.1 days. No statistically significant differences were found in the time to resumption of a regular diet or to discharge between patients undergoing ileal conduits versus orthotopic ileal neobladders. Only 1 patient had any gastrointestinal dysfunction (ileus), and this patient was discharged on postoperative 7. No patient had any delayed complications involving problems with diet intolerance or other gastrointestinal dysfunction. The results of the current series were compared with those of historical controls.

CONCLUSIONS

Advancements in preoperative, intraoperative, and postoperative management have together been successfully used in our patient population to reduce morbidity and improve recovery with regard to the early institution of an oral diet and early hospital discharge.

摘要

目的

概述我们目前对接受根治性膀胱切除术和尿流改道患者的围手术期治疗,该治疗利用围手术期护理的进展,实现早期经口进食和早期出院,从而全面改善该手术后患者的恢复情况和预后。

方法

2001年至2002年,40例连续患者接受了根治性膀胱切除术和尿流改道,目的是治愈疾病。所有患者均遵循一项护理计划,该计划包括术前、术中和术后护理的改进。术前护理包括使用磷酸钠溶液进行有限的门诊肠道准备和患者教育。手术改进包括缩短切口长度、初始腹膜前剥离以及使用内部手术吻合器。术后护理包括使用促动力药物、早期拔除鼻胃管、使用非麻醉性镇痛药以及早期经口进食。评估经口进食时间、常规饮食耐受性和出院情况等结果。

结果

平均手术时间为3.9小时,平均估计失血量为573毫升。开始进食清流食的平均时间为2.0天,开始进食常规饮食的平均时间为4.2天。平均出院时间为5.1天。在接受回肠导管术与原位回肠新膀胱术的患者之间,恢复常规饮食或出院的时间没有统计学上的显著差异。只有1例患者出现任何胃肠道功能障碍(肠梗阻),该患者于术后第7天出院。没有患者出现任何与饮食不耐受或其他胃肠道功能障碍相关的延迟并发症。将本系列结果与历史对照结果进行了比较。

结论

术前、术中和术后管理的进展已成功应用于我们的患者群体,以降低发病率,并在早期经口进食和早期出院方面改善恢复情况。

相似文献

1
Reducing time to oral diet and hospital discharge in patients undergoing radical cystectomy using a perioperative care plan.采用围手术期护理计划缩短根治性膀胱切除术患者恢复经口饮食和出院的时间。
Urology. 2003 Oct;62(4):661-5; discussion 665-6. doi: 10.1016/s0090-4295(03)00651-4.
2
Multimodal perioperative plan for radical cystectomy and intestinal urinary diversion. I. Effect on recovery of intestinal function and occurrence of complications.根治性膀胱切除术及肠道尿流改道术的多模式围手术期方案。I. 对肠道功能恢复及并发症发生情况的影响。
Urology. 2007 Jun;69(6):1107-11. doi: 10.1016/j.urology.2007.02.062.
3
Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.根治性膀胱切除术和尿流改道术患者术前机械性肠道准备的消除。
Urol Oncol. 2013 Jan;31(1):32-5. doi: 10.1016/j.urolonc.2010.11.002. Epub 2011 Jun 29.
4
Current perioperative management of radical cystectomy with intestinal urinary reconstruction for muscle-invasive bladder cancer and reduction of the incidence of postoperative ileus.肌肉浸润性膀胱癌根治性膀胱切除术联合肠道尿路重建的当前围手术期管理及降低术后肠梗阻的发生率
Surg Oncol. 2008 Jul;17(1):41-8. doi: 10.1016/j.suronc.2007.09.003. Epub 2007 Oct 24.
5
Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion.阿维莫潘可使根治性膀胱切除术后及尿流改道术患者快速恢复胃肠功能,且无需鼻胃管减压。
Can J Urol. 2012 Jun;19(3):6293-8.
6
Fast track program in patients undergoing radical cystectomy: results in 362 consecutive patients.快速通道计划在接受根治性膀胱切除术的患者中的应用:362 例连续患者的结果。
J Am Coll Surg. 2010 Jan;210(1):93-9. doi: 10.1016/j.jamcollsurg.2009.09.026. Epub 2009 Oct 28.
7
Causes of increased hospital stay after radical cystectomy in a clinical pathway setting.临床路径环境下根治性膀胱切除术后住院时间延长的原因。
J Urol. 2002 Jan;167(1):208-11.
8
Multi-institutional outcomes and cost effectiveness of using alvimopan to lower gastrointestinal morbidity after cystectomy and urinary diversion.多机构使用阿维莫潘降低膀胱切除术后和尿流改道后胃肠道发病率的结果及成本效益。
Can J Urol. 2014 Apr;21(2):7222-7.
9
Enhanced recovery protocol after radical cystectomy for bladder cancer.膀胱癌根治性膀胱切除术后的加速康复方案。
J Urol. 2014 Jul;192(1):50-5. doi: 10.1016/j.juro.2014.01.097. Epub 2014 Feb 8.
10
Early removal of nasogastric tube is beneficial for patients undergoing radical cystectomy with urinary diversion.根治性膀胱切除术+尿流改道术患者尽早拔除鼻胃管有益。
Int Braz J Urol. 2011 Jan-Feb;37(1):42-8. doi: 10.1590/s1677-55382011000100006.

引用本文的文献

1
Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series.单一术者前瞻性病例系列中加速康复外科方案的初步结果。
Medicina (Kaunas). 2022 Sep 6;58(9):1234. doi: 10.3390/medicina58091234.
2
Clinical efficacy and safety of enhanced recovery after surgery for patients treated with radical cystectomy and ileal urinary diversion: a systematic review and meta-analysis of randomized controlled trials.根治性膀胱切除术和回肠膀胱术患者术后加速康复的临床疗效和安全性:一项随机对照试验的系统评价和荟萃分析
Transl Androl Urol. 2020 Aug;9(4):1743-1753. doi: 10.21037/tau-19-941.
3
Enhanced recovery after surgery (ERAS) protocols in patients undergoing radical cystectomy with ileal urinary diversions: A randomized controlled trial.
接受根治性膀胱切除术并行回肠代膀胱术患者的术后加速康复(ERAS)方案:一项随机对照试验。
Medicine (Baltimore). 2020 Jul 2;99(27):e20902. doi: 10.1097/MD.0000000000020902.
4
Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.根治性膀胱切除术治疗膀胱癌的围手术期营养
Cochrane Database Syst Rev. 2019 May 20;5(5):CD010127. doi: 10.1002/14651858.CD010127.pub2.
5
The present and future enhanced recovery after surgery for bladder cancer.膀胱癌手术目前及未来的术后加速康复
Int Braz J Urol. 2018 Nov-Dec;44(6):1266-1271. doi: 10.1590/S1677-5538.IBJU.2017.0282.
6
Enhanced Recovery After Surgery Protocols in Major Urologic Surgery.大型泌尿外科手术中的术后加速康复方案
Front Med (Lausanne). 2018 Apr 9;5:93. doi: 10.3389/fmed.2018.00093. eCollection 2018.
7
Effects of Nonsteroidal Anti-Inflammatory Drugs as Patient Controlled Analgesia on Early Bowel Function Recovery after Radical Cystectomy.非甾体抗炎药作为患者自控镇痛对根治性膀胱切除术后早期肠道功能恢复的影响。
Sci Rep. 2018 Mar 15;8(1):4658. doi: 10.1038/s41598-018-22677-z.
8
Surgical and pathological outcomes of robotic-assisted radical cystectomy for bladder cancer in the community setting.社区环境下机器人辅助根治性膀胱切除术治疗膀胱癌的手术及病理结果
J Robot Surg. 2018 Jun;12(2):337-341. doi: 10.1007/s11701-017-0740-y. Epub 2017 Aug 23.
9
Landmarks in the treatment of muscle-invasive bladder cancer.肌层浸润性膀胱癌的治疗里程碑。
Nat Rev Urol. 2017 Sep;14(9):565-574. doi: 10.1038/nrurol.2017.82. Epub 2017 Jul 4.
10
Enhanced recovery program (ERP) in major laryngeal surgery: building a protocol and testing its feasibility.主要喉部手术中的强化康复计划(ERP):制定方案并测试其可行性。
Acta Otorhinolaryngol Ital. 2017 Dec;37(6):475-478. doi: 10.14639/0392-100X-1091.